0

Santhera Pharmaceuticals Holding AG (SANN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Publisher Name :
Date: 18-May-2017
No. of pages: 30

Summary

Santhera Pharmaceuticals Holding AG (Santhera) is a pharmaceutical company that develops and commercializes novel pharmaceutical products indicated for patients with rare mitochondrial diseases. It specifically focuses in the area of neuromuscular and neuro-ophthalmological conditions. The company’s lead product candidate, Raxone (idebenone), is developed for the treatment of Leber’s hereditary optic neuropathy. Raxone is also investigated for other diseases such as Duchenne Muscular Dystrophy and Primary Progressive Multiple Sclerosis. Santhera’s pipeline also includes other compound namely, omigapil for congenital muscular dystrophies. It operates along with its subsidiaries located in Switzerland, Germany, Canada, Finland and the US. Santhera is headquartered in Liestal, Switzerland.

Santhera Pharmaceuticals Holding AG (SANN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

– Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
– Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
– Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
– Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
– Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
– Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
– Business Description – A brief description of the company’s operations.
– Key Employees – A list of the key executives of the company.
– Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
– Key Competitors – A list of the key competitors of the company.
– Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
– The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
– The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
– Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
– The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
– Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
– Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of content
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Santhera Pharmaceuticals Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Santhera Pharmaceuticals Holding AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Santhera Pharmaceuticals Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Santhera Pharmaceuticals Holding AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Santhera Pharmaceuticals Holding AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Santhera Pharmaceuticals Holding AG, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Santhera Pharma Enters into Distribution Agreement with Pharmathen Pharma 10
Licensing Agreements 10
Santhera Pharma Amends Licensing Agreement With Ipsen For Fipamezole 10
Equity Offering 12
Santhera Pharma Raises USD53.3 Million in Private Placement of Shares 12
Santhera Pharma Raises USD28 Million through Private Placement of Shares 13
Santhera Pharma Raises USD15 Million in Public Offering of Shares 14
Santhera Pharma Completes Private Placement Of Shares For US$1 Million 15
Santhera Pharma Announces Private Placement Of Units For US$11 Million 16
Debt Offering 17
Santhera Pharma Raises USD60.2 Million in Public Offering of 5% Bonds Due 2022 17
Santhera Pharmaceuticals Holding AG - Key Competitors 18
Key Employees 19
Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Mar 07, 2017: Santhera Delivered Solid Performance in 2016 and Advances All Programs 21
Jan 26, 2017: Santhera Reports Preliminary Key Financial Figures For 2016 And Provides Corporate Update 23
Sep 06, 2016: Santhera Announces Financial Results for the First Half Year 2016 and Reports Solid Sales Growth - Company Starts to Build us Operations and Strengthens Board Of Directors 24
Apr 12, 2016: Santhera Reports Increase in Product Sales, Positive Net Result for 2015 and Progress in All Programs 27
Corporate Communications 29
Oct 04, 2016: Santhera announces appointment of Kristina Timdahl as Chief Medical Officer and Head of Development as of January 2017 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Santhera Pharmaceuticals Holding AG, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Santhera Pharmaceuticals Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Santhera Pharmaceuticals Holding AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Santhera Pharmaceuticals Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Santhera Pharmaceuticals Holding AG, Deals By Therapy Area, 2011 to YTD 2017 8
Santhera Pharmaceuticals Holding AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Santhera Pharma Enters into Distribution Agreement with Pharmathen Pharma 10
Santhera Pharma Amends Licensing Agreement With Ipsen For Fipamezole 10
Santhera Pharma Raises USD53.3 Million in Private Placement of Shares 12
Santhera Pharma Raises USD28 Million through Private Placement of Shares 13
Santhera Pharma Raises USD15 Million in Public Offering of Shares 14
Santhera Pharma Completes Private Placement Of Shares For US$1 Million 15
Santhera Pharma Announces Private Placement Of Units For US$11 Million 16
Santhera Pharma Raises USD60.2 Million in Public Offering of 5% Bonds Due 2022 17
Santhera Pharmaceuticals Holding AG, Key Competitors 18
Santhera Pharmaceuticals Holding AG, Key Employees 19
Santhera Pharmaceuticals Holding AG, Subsidiaries 20

List of Figures
Santhera Pharmaceuticals Holding AG, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Santhera Pharmaceuticals Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Santhera Pharmaceuticals Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Santhera Pharmaceuticals Holding AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Santhera Pharmaceuticals Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Santhera Pharmaceuticals Holding AG, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Santhera Pharmaceuticals Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Santhera Pharmaceuticals Holding AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

News

  • Understanding the Need For Travel Vaccination
  • If you are getting ready for a particular trip that can see you away from your house for about a month or so, then it is necessary for you to take the help of travel vaccinations. Not ...
  • The Work Of The Ophthalmology Specialist
  • When we consider ophthalmology as a branch of science, it is actually about the treatment as well as getting to diagnose the different kinds of diseases and the disorder that is to ...
  • The Process Of Dental Implants And The Subsequent Recovery
  • In the United States of America, the fear of going to a dentist happens to rank number one on the list of children as well as adults. Most of the people are actually concerned when ...
  • The medication that can help the rural population
  • It is not always that you get to see world class hospitals in the rural areas, be it America or any other country. Hence, it is important that people actually take the help of tele-medication, ...
  • The Future of Telemedicine & Its Use
  • When talking about telemedicine, you do get to realize that it is the healthcare of the future. Most of the people do not realize the implications, and for more so the time, telemedicine ...

Get Updates

Share This Post

Recent Posts

© 2021 RnR Company Profiles. All rights reserved.